Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma (Q73599937)
Jump to navigation
Jump to search
scientific article published on 01 July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma |
scientific article published on 01 July 2003 |
Statements
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma (English)
John P Leonard
Morton Coleman
Jamie C Ketas
Amy Chadburn
Scott Ely
Richard R Furman
William A Wegener
Hans J Hansen
Heather Ziccardi
Michael Eschenberg
Urte Gayko
Alessandra Cesano
David M Goldenberg